Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by a progressive-fibrosing phenotype. IPF has been associated with aberrant HDAC activities confirmed by our immunohis

NIAID Data Ecosystem40

Effect of pirfenidone on serum-stimulated human lung fibroblasts

特发性肺纤维化治疗

药物机制研究

Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease with a poor prognosis. Fibroblasts and myofibroblasts are the key cells in the fibrotic process. Pirfenidone was approved as an anti-fi

NIAID Data Ecosystem10

Supplementary Material for: Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis

特发性肺纤维化治疗

药物同情用药评估

Background: Nintedanib is approved for the treatment of idiopathic pulmonary fibrosis (IPF) and has been shown to slow disease progression by reducing annual lung function decline. Objective: To evalu

NIAID Data Ecosystem50

Idiopathic Pulmonary Fibrosis Network (IPFNet) Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis (IPFNet-STEP-IPF-BioLINCC)

特发性肺纤维化治疗

临床评估

**Data Access NOTE**: Please refer to the "Authorized Access" section below for information about how access to the data from this accession differs from many other dbGaP accessions. **Objectives**

DataCite Commons2026-04-09 更新10

Comparison of clinical outcomes in IPF patients with and without statin use.

资源简介：

相关数据集